Senior vice president and chief medical officerAmarin Corp.
The ability to collect and analyze data from a wide variety of sources, combining clinical trials with real-world evidence, can help fine-tune findings and improve cardiovascular care.
Providers face numerous challenges in their transition to VBC. Nandini Rangaswamy, Executive VP and Chief Strategy Officer, Zeomega discusses some key strategies and approaches, including dedicated population health systems, to help make the transition smooth.
